Effect of Butyrogenic Fibers in IBS Patients

• Status: Unknown status
• Trial end date: 2005-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

Despite there being no clearcut advantages, one of the most common recommendations in IBS management is to increase the amount of dietary fibres. In some IBS patients fibres have a deleterious effect on pain and bloating. It has been shown that butyrate can increase colonic sensitivity in rats. Our purpose is to study whether butyrogenic fibres can modify rectal sensitivity and symptoms in IBS and healthy control through a modification of colonic flora.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University Hospital, Clermont-Ferrand
• Collaborators: EA 3848 UdA; ERT-CIDAM; ERT: Clinical Trial Technology Solutions; Institut National de la Recherche Agronomique

Criteria

Inclusion Criteria:

• Female aged 18-60 years

• Normal volunteers and patients with IBS assessed by Rome II criteria

• Effective contraception

• Affiliated to National Health Service

• Having received oral and written information about the study

• Having provided her written informed consent

Exclusion Criteria:

• Significant clinical or biological abnormality

• Organic gastrointestinal disease

• Subjects having lower than 15g/day or higher than 20g/day fibres intake

• Antibiotic treatment during the month preceding the pre inclusion day

• Antispasmodics, antidiarrheics, laxatives, and prokinetics during the week preceding the pre inclusion day and during all the study period.

• Digestive surgery tract except appendectomy and cholecystectomy

• Alcohol abuse

• Drug addiction

• Major psychiatric disorder